Promega UK Launches New CPD-Accredited Training Programme for Life Science Professionals

Promega UK, Southampton, UK. (24 September 2025) a leading provider of innovative solutions and technical support to the life sciences industry, has just announced the launch of a new programme of Continuing Professional Development (CPD) courses, designed to support those working in the clinical field of life sciences including biomedical scientists, pathologists, and life science researchers in meeting professional development requirements and strengthening technical expertise.

 

The new courses, accredited by The CPD Standards Office, address the evolving skills gap in pathology and biomedical science by providing practical, flexible training in key laboratory techniques. Areas of focus include cell biology, genomics, protein analysis, and bioluminescent technologies, skills that are essential for modern biomedical research and diagnostics.

The five current accredited CPD modules (registered with The CPD Standards Office) are:

 

• Analysis of Circulating Cell-Free DNA to Monitor MSI-H Colorectal Tumor Response to Immunotherapy
• Current Gold Standards for MSI Testing and the Clinical Relevance of the MSI-H Biomarker
• To Nanodrop® or Not to Nanodrop®: Choosing the Most Appropriate Method for Nucleic Acid Quantitation
•  Liquid Biopsies: The Role of Circulating Cell-Free DNA
• Innovative Solutions in Nucleic Acid Extraction: Enhanced Efficiency with New Maxwell® Chemistries

 

Promega provides high-quality, CPD-accredited courses designed to support laboratory professionals in maintaining their certifications and advancing their knowledge in the latest developments in clinical and research settings. With decades of experience, Promega is a trusted worldwide leader in life science research and clinical diagnostics.

 

“There is a clear demand for accessible, accredited training that helps academic and clinical researchers, laboratory technicians, and professionals keep pace with advances in science,” said Lindsay Megenhardt, Ph.D., CHES, Medical Science Liaison in the Medical Affairs Department at Promega. “Our CPD programme has been developed to provide recognised learning that supports professional requirements while offering immediate relevance to day-to-day laboratory practice.”

 

The launch of the CPD programme reinforces Promega’s commitment to supporting the UK clinical research and diagnostic community, not only through innovative tools and reagents, but also through tailored educational resources.

 

Researchers, pathologists, and laboratory professionals can now register for CPD courses on the Promega UK website.

For more information about Promega, visit www.promega.co.uk

For more information contact:
​
Ann Brine

Contacts:
Ann Brine MA FCIM
Head of Marketing Services
Promega UK
E: ann.brine@promega.com                                                                   
T: 07739 14221

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 4,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, drug discovery and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.